AzTrials
AzTrials

Primary; CoxarthrosisCOXAMNCT06258369

Gait Initiation and Transition From Double to Single Support in Patients With Unilateral Primary Coxarthrosis

A study testing Patients with primary coxarthrosis (any stage)., Patients with primary coxarthrosis (any stage) and operated with Total Hip Prosthesis (THP). and Patients with primary coxarthrosis (any stage) and operated with RTH (Hip resurfacing). in people with Primary; Coxarthrosis, run by Lille Catholic University at 2 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The study consists to evaluate the impact of prosthetic surgery (PTH and RTH) on kinematic and dynamic parameters (joint torques) of the lower limbs during gait initiation in patients with primary coxarthrosis. Patients included in the study will undergo a three-dimensional gait analysis. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Primary; Coxarthrosis
What is being tested?
Patients with primary coxarthrosis (any stage)., Patients with primary coxarthrosis (any stage) and operated with Total Hip Prosthesis (THP). and Patients with primary coxarthrosis (any stage) and operated with RTH (Hip resurfacing).
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
2 sitesFrance
Study dates
19 Feb 2024to Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Men or women aged 18 and over
  • With primary coxarthrosis (any stage)
  • Consulting in the orthopedic departments of participating centers in anticipation of hip surgery (PTH/RTH), or for advice only.
  • Written consent signed by the patient
  • Affiliation with a social security scheme

Who cannot join

  • Disabling orthopaedic conditions:
  • Symptomatic contralateral hip/knee disease Symptomatic gonarthrosis or homolateral total knee prosthesis History of surgery on the affected hip History of fracture of the lower limb in the past year History of lower limb sprain in the last 3 months Neurological or degenerative disease
  • Pregnant or breast-feeding
  • Adults under guardianship, curatorship or safeguard of justice
  • Cognitive impairment making it impossible to understand the protocol
  • Approach other than Moore posterolateral (for PTH and RTH groups)

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Marie-Paule LEBITASY contact

+33 3 20 22 52 69

urm@ghicl.net

William's VAN DEN BERGHE contact

+33 3 20 22 57 31

VanDenBerghe.Williams@ghicl.net

France2 sites, 2 recruiting
  • CHU de Lille

    Lille, 59000

    Julien GIRARD, Julien.GIRARD@chu-lille.fr

    Julien GIRARD

    Not yet recruiting
  • Hôpital Saint-Philibert (GHICL)

    Lomme, 59462

    Pierre MARTINOT, MD, Martinot.Pierre@ghicl.net

    Pierre MARTINOT, MD

    Recruiting

Other trials in France

About this study

Official title: Gait Initiation and Transition From Double to Single Support in Patients With Unilateral Primary Coxarthrosis Who Have Not Undergone Surgery and Before/After Arthroplasty

The study consists to evaluate the impact of prosthetic surgery (PTH and RTH) on kinematic and dynamic parameters (joint torques) of the lower limbs during gait initiation in patients with primary coxarthrosis.

Patients included in the study will undergo a three-dimensional gait analysis. Dynamic gait analysis is multidimensional, measuring kinematic parameters (joint amplitudes: ankles, knees, hips, etc.) and dynamic parameters (assessment of joint torque from ankle, knee, hip to lower limb during gait initiation).

Being tested
Patients with primary coxarthrosis (any stage)., Patients with primary coxarthrosis (any stage) and operated with Total Hip Prosthesis (THP)., Patients with primary coxarthrosis (any stage) and operated with RTH (Hip resurfacing).
Keywords
Coxarthrosis, Hip, Arthroplasty, Gait initiation
Medical subject headings
Osteoarthritis, Hip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patients with primary coxarthrosis (any stage).Other

    Patients who do not undergo surgery will be called specifically for the study to attend a consultation dedicated to gait assessment.

  • Patients with primary coxarthrosis (any stage) and operated with Total Hip Prosthesis (THP).Other

    Patients scheduled for THP (Total Hip Prosthesis) will be seen at the consultation the day before surgery, in the same hospital as the THP, or at an existing dedicated consultation scheduled for all THP patients. During these scheduled visits, they will be received in the gait analysis laboratory for a gait assessment (V1). Patients will be seen again at 6 months post-operatively for a second gait assessment (V2).

  • Patients with primary coxarthrosis (any stage) and operated with RTH (Hip resurfacing).Other

    Patients scheduled for RTH (Hip Resurfacing) will be seen at the consultation the day before surgery, in the same hospital as the RTH, or at an existing dedicated consultation scheduled for all RTH patients. During these scheduled visits, they will be received in the gait analysis laboratory for a gait assessment (V1). Patients will be seen again at 6 months post-operatively for a second gait assessment (V2).

Study groups in NCT06258369
Study groupRoleWhat they receive
Patients with primary coxarthrosis (any stage).OtherNot described
Receives: Other: Patients with primary coxarthrosis (any stage).
Patients with primary coxarthrosis (any stage) and operated with Total Hip prosthesis (THP).ExperimentalNot described
Receives: Other: Patients with primary coxarthrosis (any stage) and operated with Total Hip Prosthesis (THP).
Patients with primary coxarthrosis (any stage) and operated with RTH (Hip resurfacing).ExperimentalNot described
Receives: Other: Patients with primary coxarthrosis (any stage) and operated with RTH (Hip resurfacing).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Amplitude degree of lower limbs articulations

    Measured: 6 months

  2. Dynamics of limbs joint torques during walking initiation measured in Nm/kg

    Measured: 6 months

Secondary outcomes (17)
  1. Step length during gait initiation

    Measured: 6 months

  2. Step width during gait initiation

    Measured: 6 months

  3. Duration of first step during gait initiation

    Measured: 6 months

  4. Duration of anticipatory postural adjustment phase during gait initiation

    Measured: 6 months

  5. Duration of execution phase during gait initiation

    Measured: 6 months

  6. Measurement of the trajectory during gait initiation

    Measured: 6 months

  7. Measurement of the speed during gait initiation

    Measured: 6 months

  8. Measurement of the amplitude of retreat of the center of pressure during gait initiation

    Measured: 6 months

  9. Severity of coxarthrosis according to the Tönnis classification

    The severity of coxarthrosis is assessed on radiographs according to the Tönnis classification:

    Grade Radiographic features 0 - No signs of osteoarthritis

    1. - Slight narrowing of joint space
    • Slight lipping at joint margin
    • Slight sclerosis of the femoral head or acetabulum
    1. - Small cysts in the femoral head or acetabulum
    • Increasing narrowing of joint space
    • Moderate loss of sphericity of the femoral head
    1. - Large cysts
    • Severe narrowing or obliteration of joint space
    • Severe deformity of the femoral head
    • Avascular necrosis

    Measured: 6 Months

  10. HHS (Harris Hip Score)

    The functional score consists of 10 items out of 100 points (best score = 100 points) assessing function, pain and mobility

    Measured: 6 months

  11. PMA (Postel Merle d'Aubigné) score

    Score on 3 items (pain, mobility and walking) rated on 18 points (18 = excellent results, 0 = worst result)

    Measured: 6 months

  12. Devane score

    Activity score with 5 possibilities (1 = sedentary work and 5 = power work, competitive sport)

    Measured: 6 months

  13. UCLA (University of California Los Angeles) score

    Activity score comprising 10 possibilities and assessing the intensity of physical activity (1= inactive or dependent patient, 10 = regular practice of high-impact sports)

    Measured: 6 months

  14. Vellas unipodal weight-bearing test

    This test consists in asking the patient to balance for as long as possible. A time of more than 30 seconds indicated a very low risk of falls. A time of less than 5 seconds indicates a very high risk of falls.

    Measured: 6 months

  15. Pelvic incidence

    Pelvic incidence is a constant morphologic parameter that describes the "pelvic size" based on the angular relation between femoral heads and sacral plate for any given person

    Measured: 6 months

  16. Sacral slope angle

    Spatial orientation of the pelvis in the sagittal plane is assessed by the sacral slope

    Measured: 6 months

  17. Pelvic tilt angle

    Pelvic tilt is a position-dependent parameter defined as the angle created by a line running from the sacral endplate midpoint to the center of the bifemoral heads and the vertical axis.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Feb 2024
  2. Study start19 Feb 2024
  3. Primary completion19 Aug 2027 (estimated)
  4. Study completionSep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Patients with coxarthrosis (any stage) without surgery Patients with coxarthrosis (any stage) with THP (Total Hip replacement) Patients with coxarthrosis (any stage) with RHT (Hip resurfacing)
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06258369
Sponsor's protocol ID
RC-P00122
Acronym
COXAM
Status last verified
Sep 2024
First submitted
6 Feb 2024
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Patients with primary coxarthrosis (any stage)., Patients with primary coxarthrosis (any stage) and operated with Total Hip Prosthesis (THP). and Patients with primary coxarthrosis (any stage) and operated with RTH (Hip resurfacing). in people with Primary; Coxarthrosis, run by Lille Catholic University at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Marie-Paule LEBITASY (+33 3 20 22 52 69, urm@ghicl.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Amplitude degree of lower limbs articulations (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in